What You Need to Know About Supplemental Breast Cancer Screenings in Your State

Taking charge of your breast health begins with being informed about your options. For women with dense breast tissue, early detection poses unique challenges — standard mammograms often fail to detect abnormalities in dense tissue, increasing the need for advanced screenings like MRIs and ultrasounds. These tests can be life-saving, but whether they’re covered by insurance depends heavily on where you live.

Across the United States, the landscape of coverage is uneven. Currently, 29 states and the District of Columbia mandate insurance coverage for supplemental screenings for women with dense breast tissue or abnormal mammograms. These laws aim to improve access to advanced diagnostics, bridging critical gaps in early detection and reducing the financial burden on patients.

Some states have set an even higher standard. In New York, Connecticut, and Illinois, insurers must cover supplemental screenings without requiring a copay, removing financial obstacles that often deter women from pursuing additional testing. By understanding your state’s laws and your insurance coverage, you can better advocate for your health and make informed decisions.

The chart below outlines the current status of supplemental breast cancer screening laws across the U.S., helping you navigate the landscape of coverage and ensuring you have the information you need to prioritize your health.

Note: "No law" indicates that the state has not enacted legislation requiring insurance coverage for supplemental breast imaging as of October 1, 2024.

It's important to recognize that insurance coverage can vary based on your specific plan and state regulations. For the most accurate and personalized information, consult your healthcare provider and insurance company to understand the coverage available to you.